SAREPTA THERAPEUTICS INC

.

.

SRPT seems breaking out a downward channel formation, and if it can reach its Channel breakout target, it will breakout long term resistance & can continue higher. * Trade Criteria * Date First Found- June 21, 2017 Pattern/Why- Downward channel breakout Long Entry Target Criteria- Break of $35.57 Exit Target Criteria- 1st Target $41.33, 2nd Target ...

1. Downward trend has ended. SRPT seems to be building a upward trend. 2. Stochastic RSI was at oversold area few days ago and it is crossing up to purple zone. It confirms the demand. 3. CCI is showing similar behavior, few days ago was oversold and confirms demand. 4. SRPT just hit support at $28-$30 and it is channeling up if you look at the lines I drew. 5. ...

On Finviz.com and other research, a new medication was approved today, should be reflected in PA tomorrow. Some analyzes say stock could go up 200%. Will be looking to buy stock shares and/or put options for ether weekly or monthly in this stock.RSI is pointing up and trend line on chart looks great. Look where SRPT has been, it has a lot of room for bulls to ...

.

This is one of the better looking drug stocks. There is very little resistance over the trendline.

.

After extensive research, I believe Sarepta Therapeutics Inc (NASDAQ:SRPT) will likely breakout this week. The chart has consolidated for a long period, slowly falling from over $60 after the last fantastic bit of drug news. The breakout trend line seen in the chart below continues to be hammered and should give way on the next move up. I also believe there will ...

After the stock market closed on Tuesday, Sarepta Therapeutics Inc (NASDAQ:SRPT) reported a bigger-than-expected loss of $88.5 million or $1.62 per share. In addition, investors are questioning their ability to fully launch and profit from upcoming drugs, offsetting future losses as they burn through cash. The stock took a beating after-hours, dropping almost 15% ...

I THINK ITS GOOD OPTION AND STOCK

Opinion on SRPT

NASDAQ:SRPT is already almost oversold but I think $24.2 would be a good level to buy for a long position, lets see...

Seeing double bottom at S-line

looks like higher prices in the near term

$SRPT SRPT If this baby gaps up tomorrow I'm going to go short if it spikes up into a whole dollar, then I will have my resistance right above that

Shooting for an .08 ($8) debit fill here. It's a lotto trade (which I hardly ever do), but I think that the drug will ultimately not be approved. The potential profit is $795/contract, but that's if the stock goes to "0." Additionally, it will only "play out" if there is news prior to expiry. Otherwise, it'll stay way up here.